Contineum Therapeutics CTNM
NASDAQ CTNM
$10.77 +0.21 (+1.99%)
At close: Nov 11, 2026 · 4:00 PM EST

Contineum Therapeutics (CTNM) Price to Book (2024 - 2026)

Updated

Contineum Therapeutics' Price to Book came in at 2.10 for Q3 2026, up 10.5% from 1.90 a year earlier but down 18.1% from the prior quarter.

Analysis

Contineum Therapeutics (CTNM) Price to Book (2024 - 2026) Analysis & Trends

For FY2025, Contineum Therapeutics' Price to Book was 1.63, down 14.5% from FY2024.

  • Going back by year, Price to Book was 1.91 in FY2024.
  • The five-year range for quarterly Price to Book is 0.60 (Q2 2025) to 2.56 (Q2 2026).
  • Year-over-year, Price to Book has increased for three consecutive quarters, with growth averaging 55.4% over the last six quarters.
  • Business Quant data shows CTNM's Price to Book at 2.56 (Q2 2026), 1.95 (Q1 2026) and 1.63 (Q4 2025) in the three quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Contineum Therapeutics 405.40 Mn -584.86 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 2.10
Jun 30, 2026 2.56
Mar 31, 2026 1.95
Dec 31, 2025 1.63
Sep 30, 2025 1.90
Jun 30, 2025 0.60
Mar 31, 2025 0.98
Dec 31, 2024 1.91
Sep 30, 2024 2.34
Jun 30, 2024 2.08
API Access

Contineum Therapeutics Price to Book API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-book&ticker=CTNM&period=max&api_key=YOUR_API_KEY